Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Innovation Action · Running

ONELAB Orchestrating next-generation mobile modular laboratories for pandemic monitoring preparedness

Coordinator
Stichting Amsterdam Umc, Netherlands
Runs
1 October 2022 to 30 September 2025
Status
Running
EU funding
€3.7m
Total cost
€4.4m
Partners
22 organisations in 10 countries
Type
Innovation Action
Grant agreement
101073924

What the project is doing

In the project's own words, from its summary on CORDIS.

Expert opinion from across the world recommends, & calls for, modular laboratory systems to be made available for disease monitoring missions. The WHO calls these, “Rapid Response Mobile Laboratories” (RRML). ONELAB will develop modular RRML for rapid, flexible, scalable, multi-scenario deployments into the widest range of possible settings. These next-generation facilities will support next-generation measurement-technologies/methodologies and, through satellite communications, form wide-area GIS enabled laboratory information systems.

Thus, simultaneously providing point-of-need disease detection, along with high-level situational awareness. ONELAB will also develop advanced measurement systems for a staged disease detection response. Exploiting a panel of acute viral infection biomarkers enables early detection of disease during its asymptomatic incubation. Using this at the outbreak of disease, when much is still undefined, supports effective immediate & targeted public health interventions.

Additionally, using proven methodologies developed in response to COVID 19, ONELAB will develop & demonstrate a workflow for semi-autonomous disease specific biomarker discovery. This application & delivery of agile science enhances the capability & capacity of current disease testing-strategies substantiallyRRMLs are only as good as the skilled teams who operate them. So, ONELAB builds world-wide networks & partnerships of experienced experts to: define contextually-aligned best practice; develop a consensus-driven concepts of operation; and, disseminate this though a pandemic testing playbook.

We will develop capability & capacity with training & networking-events that continue beyond the project. Finally, community mass-testing requires engagement & acceptance from all citizens, which is why we will engage with the public, & produce a citizen’s guide to mass community testing, supported by educational outreach resources.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Amsterdam UmcAmsterdamNetherlandsCoordinator
Johanniter Osterreich Ausbildung Und Forschung Gemeinnutzige GmbHWienAustriaParticipant
Solgenium OgLinzAustriaParticipant
Universitaet InnsbruckInnsbruckAustriaParticipant
JurriskHerk De StadBelgiumParticipant
Stad HasseltHasseltBelgiumParticipant
Universiteit GentGentBelgiumParticipant
Ianus Technologies LtdLarnacaCyprusParticipant
University of CyprusNicosiaCyprusParticipant
Bayerisches Rotes KreuzMunchenGermanyParticipant
G.a.s. Gesellschaft Fur Analytischesensorsysteme M.b.h.DortmundGermanyParticipant
Charokopeio PanepistimioAthinaGreeceParticipant
Panou Electronic Telecommunication Defence Equipment & Security Services Rendering Private Enterprise Commercial Handicraft SANea Filothei AthinaGreeceParticipant
Perifereia Dytiki ElladaPatrasGreeceParticipant
Telesto Technologies Pliroforikis Kai Epikoinonion EpeAthinaGreeceParticipant
Magyar VoroskeresztBudapestHungaryParticipant
Pecsi Tudomanyegyetem - University of PecsPecsHungaryParticipant
Istituto Di Sociologia Internazionale Di GoriziaGoriziaItalyParticipant
Saitama Medical University Educational CorporationSaitamaJapanParticipant
Bioxhale LtdLeicesterUnited KingdomAssociatedpartner
Imspex Diagnostics LimitedAbercynonUnited KingdomAssociatedpartner
Roboscientific LimitedElyUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI